Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
63 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Neuphoria Therapeutics Inc.’s names, not what it holds today.
Patents granted
63
63 utility, 1976 to Dec 31, 2025
Granted in 2025
2
Against 3 in 2024 and 1 in 2023
Applications published
77
1 of them in 2025
Names they are printed under
2
a former name
By yearGrantedApplications published
'11'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals6
Organic fine chemistry3
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Bionomics Limited a former name
AU, as the owner printed on each patent. 1 more under the same name are not counted (printed in CA)
41 publishedBionomics Limited a former name
named as the applicant on its applications, in AU
36 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Sep 9, 2025 | 12,409,140 | Therapeutic formulations and uses thereof | Pharmaceuticals | Bionomics Limited |
| Apr 15, 2025 | 12,275,732 | Cyclic compounds as receptor modulating therapeutics and methods and uses thereof | Pharmaceuticals | Bionomics Limited |
| Nov 12, 2024 | 12,139,473 | Substituted-N-heteroaryl compounds and uses thereof | Organic fine chemistry | Bionomics Limited |
| Sep 17, 2024 | 12,090,146 | Substituted-pyridinyl compounds and uses thereof | Pharmaceuticals | Bionomics Limited |
| Jan 30, 2024 | 11,884,673 | Modulators of ion channel receptors and uses thereof | Organic fine chemistry | Bionomics Limited |
| May 23, 2023 | 11,655,304 | Antibody and checkpoint inhibitor combination therapy | Pharmaceuticals | Bionomics Limited |
| Oct 25, 2022 | 11,478,445 | Method for treating acute myeloid leukemia | Pharmaceuticals | Bionomics Limited |
| Jul 12, 2022 | 11,384,085 | Modulators of ion channel receptors and uses thereof | Organic fine chemistry | Bionomics Limited |
| Mar 23, 2021 | 10,954,231 | Anxiolytic compounds | Pharmaceuticals | Bionomics Limited |
| Aug 18, 2020 | 10,745,487 | Method of treating cancer by administering an anti-LGR5 monoclonal antibody | Pharmaceuticals | Bionomics Limited |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Jul 3, 2025 | 2025/0214998 | CYCLIC COMPOUNDS AS RECEPTOR MODULATING THERAPEUTICS AND METHODS AND USES THEREOF | Pharmaceuticals | Bionomics Limited |
| Oct 31, 2024 | 2024/0360241 | HUMANIZED ANTIBODIES THAT BIND LGR5 | Pharmaceuticals | Bionomics Limited |
| Aug 8, 2024 | 2024/0262825 | PAIN TREATING COMPOUNDS AND USES THEREOF | Organic fine chemistry | Bionomics Limited |
| May 11, 2023 | 2023/0147869 | THERAPEUTIC FORMULATIONS AND USES THEREOF | Pharmaceuticals | Bionomics Limited · patent 12,409,140 granted from it |
| Aug 11, 2022 | 2022/0251099 | MODULATORS OF ION CHANNEL RECEPTORS AND USES THEREOF | Organic fine chemistry | Bionomics Limited · patent 11,884,673 granted from it |
| Apr 14, 2022 | 2022/0112176 | SUBSTITUTED-N-HETEROARYL COMPOUNDS AND USES THEREOF | Organic fine chemistry | Bionomics Limited · patent 12,139,473 granted from it |
| Feb 10, 2022 | 2022/0040163 | SUBSTITUTED-PYRIDINYL COMPOUNDS AND USES THEREOF | Pharmaceuticals | Bionomics Limited · patent 12,090,146 granted from it |
| Nov 18, 2021 | 2021/0355124 | Cyclic compounds as receptor modulating therapeutics and methods and uses thereof | Pharmaceuticals | Bionomics Limited · patent 12,275,732 granted from it |
| Jul 29, 2021 | 2021/0230165 | MODULATORS OF ION CHANNEL RECEPTORS AND USES THEREOF | Organic fine chemistry | Bionomics Limited · patent 11,384,085 granted from it |
| Jul 29, 2021 | 2021/0230157 | PAIN TREATING COMPOUNDS AND USES THEREOF | Organic fine chemistry | Bionomics Limited |
What it applied for, 2024 to 2025: Pharmaceuticals 2 · Organic fine chemistry 1.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.